Publication:
Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Findings From the Phase 3 PREVENT Study

dc.authorwosidNakashima, Ichiro/Aac-3073-2019
dc.authorwosidOreja-Guevara, Celia/N-5151-2019
dc.authorwosidLevy, Michael/A-3268-2011
dc.authorwosidTerzi̇, Murat/Aaa-1284-2021
dc.authorwosidWang, Kaichen/Iuq-5705-2023
dc.authorwosidPittock, Sean/Ael-3538-2022
dc.authorwosidPalace, Jacqueline/Aff-7912-2022
dc.contributor.authorFujihara, Kazuo
dc.contributor.authorBerthele, Achim
dc.contributor.authorKim, Ho Jin
dc.contributor.authorLevy, Michael
dc.contributor.authorNakashima, Ichiro
dc.contributor.authorOreja-Guevara, Celia
dc.contributor.authorWingerchuk, Dean M.
dc.date.accessioned2025-12-11T00:50:13Z
dc.date.issued2020
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Fujihara, Kazuo; Oreja-Guevara, Celia; Wingerchuk, Dean M.] Tohoku Univ, Sendai, Miyagi, Japan; [Fujihara, Kazuo; Wingerchuk, Dean M.] Fukushima Med Univ, Fukushima, Japan; [Fujihara, Kazuo; Wingerchuk, Dean M.] Southern TOHOKU Res Inst Neurosci STRINS, Koriyama, Fukushima, Japan; [Berthele, Achim] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany; [Kim, Ho Jin] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea; [Levy, Michael] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Levy, Michael] Harvard Med Sch, Boston, MA 02115 USA; [Levy, Michael] Johns Hopkins Univ, Baltimore, MD USA; [Nakashima, Ichiro] Tohoku Med & Pharmaceut Univ, Sendai, Miyagi, Japan; [Oreja-Guevara, Celia] Hosp Univ Cliin San Carlos, Madrid, Spain; [Palace, Jacqueline] John Radcliffe Hosp, Oxford, England; [Pittock, Sean J.] Mayo Clin, Rochester, MN USA; [Terzi, Murat] Ondokuz Mayis Univ, Samsun, Turkey; [Totolyan, Natalia] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia; [Viswanathan, Shanthi] Kuala Lumpur Hosp, Kuala Lumpur, Malaysia; [Wang, Kai-Chen] Cheng Hsin Gen Hosp, Taipei, Taiwan; [Wang, Kai-Chen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Pace, Amy; Yountz, Marcus; Miller, Larisa; Tanvir, Imran] Alex Pharmaceut, Boston, MA USA; [Armstrong, Roisin] Mayo Clin, Scottsdale, AZ USAen_US
dc.description.woscitationindexScience Citation Index Expanded - Conference Proceedings Citation Index - Science
dc.identifier.issn0028-3878
dc.identifier.issn1526-632X
dc.identifier.issue15en_US
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://hdl.handle.net/20.500.12712/39606
dc.identifier.volume94en_US
dc.identifier.wosWOS:000536058002150
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofNeurologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleBenefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Findings From the Phase 3 PREVENT Studyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files